Fig 1: Levels of nesfatin-1, GH and IGF-1 in response to CO or the cluster of the other four MetS risk factors alone as well as CO in conjunction with the cluster of the other four MetS risk factors. Nesfatin-1 level of subjects with/without the cluster of four MetS risk factors regardless of the status of CO (RFNO and RFO vs NRFNO and NRFO) (A). Nesfatin-1 level of subjects with/without CO regardless of the status of the cluster of four MetS risk factors (NRFNO and RFNO vs NRFO and RFO) (B). Comparison of Nesfatin-1 level among subjects with no MetS risk factors (NRFNO), central obese only (NRFO), the cluster of the other MetS risk factors other than central obese (RFNO), and all MetS risk factors (RFO) (C). Growth hormone level of subjects with/without the cluster of four MetS risk factors regardless of the status of CO (RFNO and RFO vs NRFNO and NRFO) (D). Growth hormone level of subjects with/without CO regardless of the status of the cluster of four MetS risk factors (NRFNO and RFNO vs NRFO and RFO) (E). Comparison of growth hormone level among subjects with no MetS risk factors (NRFNO), central obese only (NRFO), the cluster of the other MetS risk factors other than central obese (RFNO), and all MetS risk factors (RFO) (F). Insulin-like growth factor-1 level of subjects with/without the cluster of four MetS risk factors regardless of the status of CO (RFNO and RFO vs NRFNO and NRFO) (G). Insulin-like growth factor-1 level of subjects with/without CO regardless of the status of the cluster of four MetS risk factors (NRFNO and RFNO vs NRFO and RFO) (H). Comparison of Insulin-like growth factor-1 level among subjects with no MetS risk factors (NRFNO), central obese only (NRFO), the cluster of the other MetS risk factors other than central obese (RFNO), and all MetS risk factors (RFO) (I).